Creso Pharma (ASX:CPH) share price lifts following two positive updates

It's been a tough year for shareholders of this cannabis product developer but there's good news today.

| More on:
cannabis farmer in the fields checking the crops

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Creso Pharma Ltd (ASX: CPH) share price edged higher during morning trade after the company announced the launch of new e-commerce channels and its first purchase order from Poland.

The Creso share price rose by more than 8% above yesterday's close to 13 cents, before settling back to 12 cents in mid-afternoon trade.

Creso expands market presence

According to the release, Creso advised it has increased its European market presence with the launch of an e-commerce channel and marketing campaign. The online platform will sell a range of new human health products designed for sport, health and wellness.

This marks the first time Creso has utilised an e-commerce platform to unlock a new potential revenue stream.

The platform underwent a special development process with input from potential customers, suppliers and consumers. It will initially target Swiss customers and then expand throughout Europe.

Switzerland represents a large addressable market of CHF 21 billion (A$31 billion) for sports-related activities.

Creso will undertake an active marketing campaign using direct mailouts and social media targeting consumers.

The company also announced that it has received its first purchase order from Poland. The company that placed the order is the Polish medical and pharmaceutical company, Polvet.

The order consists of Creso hemp flour-based, anibidiol granule product for pets, large companion animals and livestock. Valued at roughly $80,000, the products will be used in Polvet's animal clinics and distributed through established channels.

Creso head of international operations Jorge Wernli commented:

Creso Pharma's European operations continue to grow … This represents a key strategic milestone in broadening our global footprint, as well as our presence in sports and recreational markets.

We will continue to pursue growth opportunities across Europe and can now focus on both business to business and direct to consumer paths. The Company will continue to update shareholders on progress in the coming months.

About the Creso share price

This year has been challenging for Creso shareholders. The Creso share price has fallen 33% year to date and 7.7% over the past month.

Creso has a market capitalisation of approximately $144.2 million with 1.2 billion shares on issue.

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

Two workers at an oil rig discuss operations.
Broker Notes

Should you buy Santos, Beach Energy or Woodside shares? Here's Macquarie's top pick

Macquarie has released its new share price expectations for Santos, Beach Energy and Woodside shares.

Read more »

A green fully charged battery symbol surrounded by green charge lights representing the surging Vulcan share price today
Share Market News

Up 300% in 6 months! This soaring ASX lithium stock just took a major step to production

Marching forward.

Read more »

An old-fashioned panel of judges each holding a card with the number 10
Share Gainers

Here are the top 10 ASX 200 shares today

It was a happy end to the trading week this Friday.

Read more »

Broker written in white with a man drawing a yellow underline.
Broker Notes

Brokers name 3 ASX shares to buy today

Here's why brokers are feeling bullish about these three shares this week.

Read more »

A young man pointing up looking amazed, indicating a surging share price movement for an ASX company
Share Market News

Macquarie says this top ASX tech stock could rise 15%

Let's see what the broker is saying about this stock.

Read more »

Excited couple celebrating success while looking at smartphone.
Healthcare Shares

Up 680% since July, here's why 2025 was a breakout year for this hot ASX stock

With consistent contract wins, FDA clearance, and backing from Pro Medicus, 4D Medical is showing that there is a commercial…

Read more »

A male investor wearing a blue shirt looks off to the side with a miffed look on his face as the share price declines.
Share Fallers

Why Collins Foods, Monash IVF, Premier Investments, and Step One shares are tumbling today

These shares are ending the week in the red. But why?

Read more »

A bearded man holds both arms up diagonally and points with his index fingers to the sky with a thrilled look on his face over these rising Tassal share price
Share Gainers

4 ASX 200 stocks smashing the benchmark this week

Investors have been piling into these four ASX 200 stocks this week. Let’s see why.

Read more »